Detection of cellular immunity to rabies antigens in human vaccinees

Journal of Clinical Immunology

Volumn 26, Issue 6, 2006, Pages 533-545

  Moore, Susan M ^a   Wilkerson, Melinda J ^a   Davis, Rolan D ^a   Wyatt, Carol R ^a   Briggs, Deborah J ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Carboxyfluoroscein succinimidyl ester; Cytokines; Flow cytometry; In vitro proliferation; Rabies; Vaccine response

Indexed keywords

CYTOKINE; ESTER DERIVATIVE; NEUTRALIZING ANTIBODY; RABIES VACCINE; THYMIDINE; VIRUS ANTIGEN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOSTIMULATION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RABIES VIRUS; STANDARD; STATISTICAL ANALYSIS; VACCINATION; VIRUS TITRATION;

ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, CD4; ANTIGENS, CD8; CELL LINE; CELL PROLIFERATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; FLUORESCEINS; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; RABIES VACCINES; RABIES VIRUS; SUCCINIMIDES; VACCINATION; VIRAL PROTEINS;

EID: 33751104171     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-006-9044-0     Document Type: Article

References (24)

1. Haupt W: Rabies-Risk of exposure and current trends in prevention of human cases. Vaccine 17:1742-1749, 1999
2. Dietzschold B, Morimoto K, Hooper DC: Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr Top Microbiol Immunol 253:145-155, 2001
3. Hooper DC, Sauder C, Scott GS, Dietzschold B, Richt JA: Immunopathology and immunoprotection in CNS virus infections: Mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 265:163-182, 2002
4. Kuwert EK, Barsenbach J, Werner J, Marcus I, Scheiermann N, Grosse-Wilde H et al.: Early/high and late/low responders among HDCS vaccinees. In Cell Culture Rabies Vaccines and Their Protective Effect in Man, EK Kuwert, RJ Wiktor, H Koprowski (eds). Geneva, International Green Cross, 1981, pp 160-168
5. Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A: Predictive factors for the neutralizing antibody response following preexposure rabies immunization: Validation of a new booster dose strategy. Vaccine 18:2661-2667, 2000
6. Aubert MF: Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735-760, 1992
7. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711-3719, 1998
8. Garenne M, Lafon M: Sexist diseases. Perspect Biol Med 41:176-189, 1998
9. Lafon M: Immunology. In Rabies, AC Jackson, WH Wunner (eds). San Diego, CA, Academic Press, 2002, pp 351-371
10. Hooper DC: The role of immune responses in the pathogenesis of rabies. J Neurovirol 11:88-92, 2005
11. Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, et al.: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287-292, 1994
12. Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M: T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 85:224-230, 1991
13. Fulcher D, Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77:559-564, 1999
14. Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK: A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99-112, 1999
15. Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535-541, 1973
16. Habel K: Habel test for potency. In Laboratory Techniques in Rabies, FX Meslin, MM Kaplan, H Koprowski (eds). Geneva, World Health Organization, 1996, pp 369-373
17. Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 48: 1-21. United States, Morbidity and Mortality Weekly Report, 1999
18. World Health Organization: World Health Organization Expert Committee on Rabies: Eighth Report. 824. Geneva, WHO Press, WHO Technical Report Series, 1992
19. Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991
20. Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al.: Memory T cells and vaccines. Vaccine 21:419-430, 2003
21. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D et al.: Evidence for a viral superantigen in humans. Nature 358:507-510, 1992
22. Wells AD, Gudmundsdottir H, Turka LA: Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173-3183, 1997
23. Maino VC: Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry. Vet Immunol Immunopathol 63:199-207, 1998
24. Lagrelius M, Jones P, Franck K, Gaines H: Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33:156-165, 2006